Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 6;11(19):5899.
doi: 10.3390/jcm11195899.

Clinical Characteristics of Actinic Keratosis Associated with the Risk of Progression to Invasive Squamous Cell Carcinoma: A Systematic Review

Affiliations
Review

Clinical Characteristics of Actinic Keratosis Associated with the Risk of Progression to Invasive Squamous Cell Carcinoma: A Systematic Review

Alise Balcere et al. J Clin Med. .

Abstract

Background: Actinic keratosis (AK) is one of the most common lesions on chronically sun-damaged skin that has the risk of progression to invasive squamous cell carcinoma (SCC). With the possibilities of using digital technologies for following-up skin lesions and their increased use in the past few decades, our objective was to update the review by Quaedvlieg et al., 2006, and to review prospective studies from 2005 onwards to identify the clinical characteristics of AK that later progressed to SCC.

Methods: The PubMed, Scopus, and ScienceDirect databases were searched for relevant articles. The search had the following criteria: English language, human subjects and year from 2005 onwards. The study protocol was registered in the Prospero database with the record number CRD42020200429 and followed the PRISMA guidelines. The risk-of-bias assessment was performed using the QUIPS tool.

Results: From the 5361 studies screened, 105 reports were evaluated for eligibility, and 2 articles with 621 patients were included. The main AK types associated with the development of SCC were found to be baseline AK, also known as a long-standing AK, and merging AK, also called an "AK patch".

Keywords: AK patch; baseline AK; keratinocyte cancer; merging AK; progression.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
PRISMA flow diagram of the article selection process. Two studies met the inclusion criteria. AK—actinic keratosis. SCC—squamous cell carcinoma.
Figure 2
Figure 2
Evaluation of risk of bias using the QUIPS tool. Both studies were considered to have an overall low risk of bias. QUIPS, Quality in Prognosis Studies [13,14].

References

    1. Dessinioti C., Stratigos A.J. Overview of Guideline Recommendations for the Management of High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. J. Eur. Acad. Dermatol. Venereol. 2022;36:11–18. doi: 10.1111/jdv.17531. - DOI - PubMed
    1. Eisen D.B., Asgari M.M., Bennett D.D., Connolly S.M., Dellavalle R.P., Freeman E.E., Goldenberg G., Leffell D.J., Peschin S., Sligh J.E., et al. Guidelines of Care for the Management of Actinic Keratosis. J. Am. Acad. Derm. 2021;85:e209–e233. doi: 10.1016/j.jaad.2021.02.082. - DOI - PubMed
    1. Grada A., Feldman S.R., Bragazzi N.L., Damiani G. Patient-Reported Outcomes of Topical Therapies in Actinic Keratosis: A Systematic Review. Dermatol. Ther. 2021;34:e14833. doi: 10.1111/dth.14833. - DOI - PMC - PubMed
    1. Fernández-Figueras M.T., Carrato C., Sáenz X., Puig L., Musulen E., Ferrándiz C., Ariza A. Actinic Keratosis with Atypical Basal Cells (AK I) Is the Most Common Lesion Associated with Invasive Squamous Cell Carcinoma of the Skin. J. Eur. Acad. Dermatol. Venereol. 2015;29:991–997. doi: 10.1111/jdv.12848. - DOI - PubMed
    1. Fernandez Figueras M.T. From Actinic Keratosis to Squamous Cell Carcinoma: Pathophysiology Revisited. J. Eur. Acad. Dermatol. Venereol. 2017;31:5–7. doi: 10.1111/jdv.14151. - DOI - PubMed